Impulsive Aggressive Behavior: Open-Label Treatment With Citalopram
J Clin Psychiatry 2003;64(1):81-85
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Background: Results from open-label and
placebo-controlled trials suggest that the selective serotonin
reuptake inhibitors reduce impulsive aggressive behavior. The
objective of this open-label study was to investigate whether
citalopram treatment has anti-aggressive effect on impulsive
aggressive subjects meeting DSM-IV criteria for a cluster B
personality disorder or intermittent explosive disorder.
Method: In this 8-week trial, subjects were
initiated on 20 mg/day of citalopram and titrated up to 60 mg/day
by the fourth week, if tolerated. The primary outcome measure was
the Overt Aggression Scale-Modified (OAS-M), a scale used to
quantify verbal and physical aggression, subjective irritability,
and overt irritability. Secondary outcome measures included the
Barratt Impulsiveness Scale and Buss-Durkee Hostility Inventory.
Results: Of 25 subjects enrolled, 20 completed
the study. The mean daily dose was 45.5 mg, and citalopram was
generally well tolerated. Statistically significant decreases
were found in the OAS-M aggression scores (32.82±19.76 to
4.73±7.57, p=.000), subjective irritability scores (3.50±0.60
to 1.45±1.18, p=.000), and overt irritability scores (3.23±0.81
to 0.91±1.02, p=.000).
Conclusion: These results suggest that
citalopram is an effective treatment for reducing impulsive